Qiagen N.V. Common Shares (NY:QGEN)

44.87 +0.12 (+0.27%)

Delayed Quote Updated: 11:27 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Qiagen N.V. Common Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

QGEN Investors Have Opportunity to Join Qiagen N.V. Fraud Investigation with the Schall Law Firm

May 06, 2026

From Schall Law

Via GlobeNewswire

QIAGEN Reports Full Results for Q1 2026

May 06, 2026

From QIAGEN N.V.

Via Business Wire

QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook

April 27, 2026

From QIAGEN N.V.

Via Business Wire

QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026

April 16, 2026

From QIAGEN N.V.

Via Business Wire

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel

April 14, 2026

From QIAGEN N.V.

Via Business Wire

Qiagen Announces Form 20-F Annual Report Filing for 2025 Results

March 20, 2026

From QIAGEN N.V.

Via Business Wire

QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention

March 19, 2026

From QIAGEN N.V.

Via Business Wire

QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System

March 10, 2026

From QIAGEN N.V.

Via Business Wire

Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity and Higher Cell Recovery

February 19, 2026

From QIAGEN N.V.

Via Business Wire

QIAGEN Exceeds Q4 2025 Outlook Driven by Growth Pillars

February 04, 2026

From QIAGEN N.V.

Via Business Wire

QIAGEN Showcases QIAsprint Connect High-Throughput Automation System for Labs Worldwide at SLAS 2026

February 03, 2026

From QIAGEN N.V.

Via Business Wire

QIAGEN Appoints Mark Stevenson to Supervisory Board

January 26, 2026

From QIAGEN N.V.

Via Business Wire

QIAGEN N.V. to Release Results for Q4 2025 and Hold Webcast

January 19, 2026

From QIAGEN N.V.

Via Business Wire

QIAGEN Sets 2026 Priorities to Drive Growth Across Five Pillars Toward Achieving 2028 Goals for Solid Profitable Growth

January 12, 2026

From QIAGEN N.V.

Via Business Wire

QIAGEN N.V. (NYSE:QGEN) Passes the "Caviar Cruise" Quality Stock Screen ↗

December 27, 2025

QIAGEN emerges as a top quality stock, showing strong growth, exceptional 40% ROIC, robust cash flow, and solid financial health for long-term investors.

Via Chartmill

Wall Street Rallies as Cooling Inflation Offsets Labor Market Fog and "Great Data Gap"

December 19, 2025

Wall Street breathed a collective sigh of relief this week as fresh economic data suggested that the "Great Data Gap" of 2025 might finally be closing with a soft landing in sight. Following a...

Via MarketMinute

QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million

December 18, 2025

From QIAGEN N.V.

Via Business Wire

QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025

November 10, 2025

From QIAGEN N.V.

Via Business Wire

Qiagen (QGEN) Q3 2025 Earnings Call Transcript ↗

November 05, 2025

Qiagen (QGEN) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings World Trade

QIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share Repurchase

November 04, 2025

From QIAGEN N.V.

Via Business Wire

QIAGEN to acquire Parse Biosciences, expanding its Sample technologies portfolio into highly scalable single-cell solutions

November 04, 2025

From QIAGEN N.V.

Via Business Wire

QIAGEN Launches New Automated Sexual Assault Sample Processing Kit at ISHI 2025

October 30, 2025

From QIAGEN N.V.

Via Business Wire

QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership in Automated Sample Processing

October 28, 2025

From QIAGEN N.V.

Via Business Wire

QIAGEN N.V. (NYSE:QGEN) Passes the Caviar Cruise Quality Investment Screen ↗

October 18, 2025

QIAGEN NV exemplifies the Caviar Cruise investing method with strong sales growth, a 46% ROIC, and robust cash flow, signaling a high-quality business.

Via Chartmill

QIAGEN N.V. to Release Results for Q3 2025 and Hold Webcast

October 13, 2025

From QIAGEN N.V.

Via Business Wire

Illumina's BioInsight Launch Sparks Optimism, Signals New Era for Genomic Data and AI

October 01, 2025

San Diego, CA – October 1, 2025 – Illumina, Inc. (NASDAQ: ILMN) saw its shares surge by 6.6% today following the announcement and immediate launch of its new business unit, BioInsight. This strategic...

Via MarketMinute

Topics Artificial Intelligence Intellectual Property

QIAGEN Secures European CE-IVDR Certification for Full QIAstat-Dx Portfolio

September 10, 2025

From QIAGEN N.V.

Via Business Wire

QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing

September 02, 2025

From QIAGEN N.V.

Via Business Wire

DoorDash To Rally Around 30%? Here Are 10 Top Analyst Forecasts For Thursday ↗

August 07, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.